Attorneys representing plaintiffs in a multidistrict litigation (MDL) against dialysis giant Fresenius Medical Care over potentially fatal cardiac effects with the company’s GranuFlo and NaturaLyte dialysis products told a judge that hundreds of Massachusetts and Mississippi cases are eligible to join the MDL because there is no proof that patients or their doctors knew about a 2012 FDA warning regarding the products. Fresenius filed a motion to toss out hundreds of cases in the MDL because they were filed three years after the FDA warning, which issued on May 25, 2012. “Defendants pin their hopes on a single FDA safety ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.